GlassScriptPhysician profile
Alexander Sbrocchi
NPI 1710336078
$13,637.02
in general payments reported to CMS, 2019-2025
32 companies · $2,970 in 2025
The $2,970 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $108 · 2021: $533 · 2022: $1,839 · 2023: $4,841 · 2024: $3,032 · 2025: $2,970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,511 · Travel and Lodging: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,511.00 |
| Travel and Lodging | $1,333.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,892.01 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Mitris Resilia Mitral Valve |
| Medtronic, INC. | $1,724.65 | 2022-2025 | Corevalve Evolut R, Avalus, Penditure |
| Atricure, INC. | $1,133.95 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Abbott Laboratories | $1,045.64 | 2019-2024 | 2nd Gen Centrimag Primary Console, Epic, Thoratec Heartmate 3 Lvas Implant Kit |
| Baxter Healthcare | $792.86 | 2021-2025 | Preveleak |
| Abiomed | $691.87 | 2022-2025 | Impella |
| Artivion, INC. | $668.78 | 2025 | Amds-Ascyrus Medical, Cardiac Non-Synergraft |
| Boston Scientific Corporation | $470.21 | 2023-2025 | Avvigo Guidance System, General - Structural Heart, Rotablator Rotational Atherectomy System Console Kit |
| W. L. Gore & Associates, INC. | $434.56 | 2022-2024 | Gore Tag Conformable Thoracic Stent Graft, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Bolton Medical INC | $393.48 | 2023-2024 | Treo Abdominal Stent-Graft System |
| Zimmer Biomet Holdings, INC. | $225.50 | 2019-2021 | |
| Kls-Martin L.P. | $201.91 | 2023-2025 | |
| Maquet Cardiovascular L.L.C. | $126.58 | 2023 | Acrobat-I Stabilizer |
| Livanova USA, INC. | $120.92 | 2019 | |
| Ethicon US, LLC | $96.38 | 2023-2025 | Echelon; Endopath, Stratafix, Enseal |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragonix Technologies, INC. | $86.78 | 2022 | |
| Depuy Synthes Sales INC. | $56.02 | 2025 | Matrixrib |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.77 | 2023-2025 | Lifevest |
| Angiodynamics, INC. | $48.94 | 2022-2023 | Angiovac |
| Corcym INC | $44.36 | 2022-2024 | Memo 4d |
| Kestra Medical Technology Services, INC. | $43.78 | 2024-2025 | Assure Wcd |
| Pylant Medical | $35.73 | 2024 | |
| Becton, Dickinson and Company | $35.25 | 2022 | |
| Haemonetics Corporation | $31.83 | 2023 | |
| Getinge USA Sales, LLC | $30.62 | 2025 | Vasoview Hemopro 2 |
| Lemaitre Vascular, INC. | $28.80 | 2025 | Restoreflow |
| Impulse Dynamics (USA) INC. | $27.59 | 2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $26.00 | 2023 | |
| Glaxosmithkline, LLC. | $20.33 | 2025 | Arexvy |
| La Jolla Pharmaceutical Company | $20.26 | 2023 | Giapreza |
| Mimedx Group, INC. | $15.77 | 2024 | |
| Biocomposites INC | $9.89 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Sbrocchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.